Background: Several inflammatory factors have been demonstrated with diagnostic or
prognostic value in patients with ischemic cardiomyopathy (ICM). Interleukin 34 (IL-34), an …

Pro-inflammatory mediators are identified in patients with heart failure (HF), some of which
may be used as biomarkers with diagnostic or prognostic value. As an additional ligand of …

Objective: This study investigated levels of interleukin (IL)-34, a proinflammatory cytokine, in
patients with coronary artery disease (CAD). Methods: Following coronary artery …

Interleukin-34 Levels Were Associated with Prognosis in Patients with Acute Myocardial
Infarction Page 1 CLINICAL STUDY Interleukin-34 Levels Were Associated with Prognosis in …

Background Accumulating evidence shows that the novel anti-inflammatory cytokine IL-35
can efficiently suppress effector T cell activity and alter the progression of inflammatory and …

Abstract Background Interleukin-34 (IL-34) is a hematopoietic cytokine and a ligand of
colony-stimulating factor 1 receptor (CSF-1R). Numerous studies have demonstrated that IL …

Objective: Despite several improvements in the management of heart failure (HF), it is still an
incurable and a progressive disease. Several trials demonstrated that the process of …

Objective: It has been reported that cytokines play a crucial role in pathogenesis of different
diseases such as cardiovascular diseases. The aim of this study was to evaluated the serum …

A great number of basic and clinical studies have demonstrated that inflammatory cytokines
play an important role in the development and progression of chronic heart failure (CHF) …

Background Renal dysfunction, commonly associated with cardiac dysfunction, has
predictive value for adverse long‐term outcomes in heart failure (HF). We previously …